Viewing Study NCT02548195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-05-16 @ 10:34 PM
Study NCT ID: NCT02548195
Status: UNKNOWN
Last Update Posted: 2015-09-14
First Post: 2015-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Sponsor: Shanghai Zhongshan Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GEMOX View
None intrahepatic cholangiocarcinoma View
None adjuvant therapy View
None oxaliplatin View
None gemcitabine View
None capecitabine View
None curative surgery View